The AlphaLISA™ SureFire® Biotin-Free Human Total MDMX assay is a sandwich immunoassay for quantitative detection of total MDMX in cellular lysates using Alpha Technology.
| Feature | Specification |
|---|---|
| Application | 細胞シグナル伝達 |
| Protocol Time | 2h at RT |
| Sample Volume | 10 µL |
The AlphaLISA™ SureFire® Biotin-Free Human Total MDMX assay is a sandwich immunoassay for quantitative detection of total MDMX in cellular lysates using Alpha Technology.
Loading...
MDMX (also known as MDM4) is a key negative regulator of the tumor suppressor p53, functioning as an oncogenic driver in a wide range of human cancers. MDMX binds to the p53 transactivation domain, inhibiting its transcriptional activity and promoting p53 degradation through recruitment of the E3 ubiquitin ligase MDM2. MDMX is structurally similar to MDM2 but lacks intrinsic ubiquitin ligase activity, instead acting as an allosteric activator of MDM2. The MDMX-p53 interaction is a critical node in the p53 signaling axis, and its dysregulation is a common mechanism by which cancer cells evade p53-mediated cell cycle arrest and apoptosis. MDMX is frequently amplified or overexpressed in tumors with wild-type p53, and small-molecule inhibitors that disrupt the MDMX-p53 interaction have emerged as a promising therapeutic strategy for restoring p53 function in cancers driven by MDMX deregulation. Quantitative assessment of MDMX expression and its relationship to p53 status can provide valuable insights into the underlying biology of p53-deficient cancers and guide the development of targeted p53-reactivating therapies.
The AlphaLISA SureFire Biotin-Free Human Total MDMX Detection Kit is a sandwich immunoassay for the quantitative detection of total MDMX in cellular lysates, using Alpha Technology.
Formats:
AlphaLISA SureFire Biotin Free kits are compatible with:
AlphaLISA SureFire Biotin Free kits can be used for:
The Total-AlphaLISA SureFire Biotin Free assay measures the expression level of a target protein in a biological sample (e.g. cell lysate).
The Total-AlphaLISA SureFire Biotin Free assay uses two antibodies which recognize two different distal epitopes on the target protein. AlphaLISA assays require two bead types: Acceptor and Donor Beads. Acceptor Beads are coated with a proprietary CaptSure™ agent to specifically immobilize the assay specific antibody, labeled with a CaptSure tag. Donor Beads are coated with a proprietary CaptSure3 agent to capture one of the detection antibodies, which is labeled with the CaptSure3 tag. In the presence of target protein, the two antibodies bring the Donor and Acceptor Beads in close proximity whereby the singlet oxygen transfers energy to excite the Acceptor Bead, allowing for the generation of a luminescent Alpha signal. The amount of light emission is directly proportional to the quantity of protein present in the sample.
The two-plate protocol involves culturing and treating the cells in a 96-well plate before lysis, then transferring lysates into a 384-well OptiPlate™ plate before the addition of Total-AlphaLISA SureFire Biotin Free detection reagents. This protocol enables cell viability and confluence to be monitored. In addition, lysates from a single well can be used to measure multiple targets.
Detection of Total target protein with AlphaLISA SureFire Biotin Free reagents can be performed in a single plate used for culturing, treatment, and lysis. No washing steps are required. This HTS designed protocol allows for miniaturization while maintaining robust AlphaLISA SureFire quality.
MCF7 cells were seeded in a 96-well plate (4,000 cells/well) in complete medium and incubated overnight at 37°C, 5% CO2.Cells were left untreated or treated with 1.25 µg/mL IGF-1 for 24 hours in serum free media.
After treatment, the cells were lysed with 100 µL of Lysis Buffer for 10 minutes at RT with shaking (350 rpm). MDMX and ERK levels were evaluated using respective AlphaLISA SureFireBiotin Freeassays. For the detection step, 10 µL of cell lysate (approximately 4,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
IGF-1 treatment induced a modest increase of MDMX expression while ERK levels remained unchanged.
MCF7 cells were seeded in a 96-well plate (4,000 cells/well) in complete medium and incubated overnight at 37°C, 5% CO2.Cells were treated with increasing concentrations of 17-AAG or SNX-2112 for 24 hours.
After treatment, the cells were lysed with 100 µL of Lysis Buffer for 10 minutes at RT with shaking (350 rpm). MDMX and ERK levels were evaluated using respective AlphaLISA SureFireBiotin Freeassays. For the detection step, 10 µL of cell lysate (approximately 4,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
As expected, HPS90 inhibitors resulted in a dose-dependent decrease of Total MDMX while ERK levels remained unchanged.
MCF7 and HCT 116 cells were seeded in a 96-well plate (4,000 cells/well) in complete medium and incubated overnight at 37°C, 5% CO2.Cells were treated with increasing concentrations of Doxorubicin for 24 hours.
After treatment, the cells were lysed with 100 µL of Lysis Buffer for 10 minutes at RT with shaking (350 rpm). MDMX and ERK levels were evaluated using respective AlphaLISA SureFire Biotin Freeassays. For the detection step, 10 µL of cell lysate (approximately 4,000 cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at RT. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
Doxorubicin treatment resulted in a dose-dependent decrease of MDMX while ERK levels remained unchanged.
Adherent cells were harvested and lysed with Lysis Buffer at a density of 4 x 106 cells/mL.
Suspension cells were harvested and lysed with Lysis Buffer at a density of 3.2 x 106 cells/mL.
Cells were lysed for 10 minutes at RT with shaking (350 rpm). MDMX levels were evaluated using the AlphaLISA SureFire Ultra Biotin Free assay. For the detection step, 10 µL of cell lysate (20,000 adherent cells or 15,000 suspension cells) was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor Mix and incubated for 1 hour at RT. Finally, 5 µL of Donor Mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
MDMX protein is broadly expressed in various human cell lines.
Cell lysate was prepared from MCF7 cells cultured to confluency in T175 flasks at 37°C, 5% CO2. Each flask was lysed in 2 mL of Lysis Buffer for 10 minutes at RT with shaking.
Lysate was serially diluted and MDMX levels were evaluated using the AlphaLISA SureFireBiotin Free assay. For the detection step, 10 µL of lysate was transferred into a 384-well white OptiPlate, followed by 5 µL of Acceptor mix and incubated for 1 hour at room temperature. Finally, 5 µL of Donor mix was then added to each well and incubated for 1 hour at RT in the dark. The plate was read on an Envision using standard AlphaLISA settings.
Approximate number of cells per datapoint is indicated. The dotted line represents assay background. The assay can detect MDMX expression in less than 1,000 cells/datapoint.
| Application |
Cell Signaling
|
|---|---|
| Automation Compatible |
Yes
|
| Brand |
AlphaLISA SureFire Biotin-Free
|
| Detection Modality |
Alpha
|
| Product Group |
Kit
|
| Protocol Time |
2h at RT
|
| Sample Volume |
10 µL
|
| Shipping Conditions |
Shipped in Blue Ice
|
| Target |
MDMX
|
| Target Class |
Phosphoproteins
|
| Target Species |
Human
|
| Technology |
Alpha
|
| Therapeutic Area |
Oncology
|
| Unit Size |
500 Assay Points
|
Are you looking for resources, click on the resource type to explore further.
The definitive guide for setting up a successful AlphaLISA SureFire Ultra assay
Several biological processes are regulated by...
Loading...
We are here to answer your questions.